Description

1. Product Overview: Sinlair is a tablet formulation of Montelukast USP 10 mg, a leukotriene receptor antagonist used in the management of asthma and allergic rhinitis.
2. Composition: Active Ingredient: Montelukast USP 10 mg | Dosage Form: Tablet
3. Pharmacological Class: Leukotriene Receptor Antagonist
4. Mechanism of Action: Montelukast blocks leukotriene D4 receptors in the airways, reducing bronchoconstriction, inflammation, and mucus production, thereby improving respiratory function.
5. Indications: Prophylaxis and chronic treatment of asthma | Allergic rhinitis (seasonal and perennial) | Prevention of exercise-induced bronchoconstriction
6. Dosage & Administration: As prescribed by physician | Oral use | Usually once daily in the evening | Can be taken with or without food
7. Clinical Benefits: Improves asthma control | Reduces frequency of asthma attacks | Relieves allergy symptoms | Convenient once-daily dosing
8. Contraindications: Hypersensitivity to Montelukast or any component
9. Precautions: Not for acute asthma attacks | Monitor for neuropsychiatric symptoms | Use under medical supervision
10. Drug Interactions: May interact with phenobarbital, phenytoin, and rifampicin
11. Special Populations: Pregnancy and lactation: Use only if clearly needed | Pediatric use: Different strengths required | Elderly: No dose adjustment usually required
12. Adverse Effects: Headache | Abdominal pain | Dizziness | Fatigue
13. Storage Conditions: Store below 30°C | Protect from light and moisture | Keep out of reach of children
14. Packaging: Tablet in blister pack
15. Manufacturer: Everest Pharmaceutical Ltd.